SA

Shaikh Affan Ahemad Shakiloddin

Active Director Director DIN 11216722
DIN 11216722 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shaikh Affan Ahemad Shakiloddin

Data last updated:

Shaikh Affan Ahemad Shakiloddin is a Director at Ancorek Pharma Private Limited (since 2025).

DIN 11216722
Primary Designation Director
First Appointment 27 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ancorek Pharma Private Limited U86100MH2025PTC453193
Director27 Jul 20252025Active

Board colleagues of Shaikh Affan Ahemad Shakiloddin

Directorship timeline

Open interactive timeline →
Ancorek Pharma Private Limited
Premium access

Shareholding and investment profile for Shaikh Affan Ahemad Shakiloddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaikh Affan Ahemad Shakiloddin

Shaikh Affan Ahemad Shakiloddin currently holds 1 directorship: Ancorek Pharma Private Limited (Director, since 27 Jul 2025).

Shaikh Affan Ahemad Shakiloddin was first appointed on 27 Jul 2025 as Director at Ancorek Pharma Private Limited.

The current boards of Shaikh Affan Ahemad Shakiloddin's companies include Aamir Afzal Khan (Ancorek Pharma Private Limited), Mohammed Danish Shaikh Irfan (Ancorek Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available